Showing 1,021 - 1,040 results of 227,229 for search '(( 50 ((we decrease) OR (mean decrease)) ) OR ( 10 ((ng decrease) OR (a decrease)) ))', query time: 1.50s Refine Results
  1. 1021
  2. 1022
  3. 1023
  4. 1024
  5. 1025

    Decrease of NF-κB activity in tumor tissue of CCR5<sup>−/−</sup> mice. by Ju Kyoung Song (324058)

    Published 2013
    “…<p><b>A</b>, The DNA binding activity of NF-κB was determined in the nuclear extracts of the CCR5<sup>−/−</sup> mice and CCR5<sup>+/+</sup> mice tumor tissues by EMSA described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0033747#s4" target="_blank">material and methods</a>. …”
  6. 1026
  7. 1027
  8. 1028
  9. 1029
  10. 1030

    Inflammatory Adipokines Decrease Expression of Two High Molecular Weight Isoforms of Tropomyosin Similar to the Change in Type 2 Diabetic Patients by Stuart A. Savill (3129060)

    Published 2016
    “…The change in expression in HMW isoforms from TPM1 and TPM4 was replicated in THP1 cells treated with 1 ng/ml TNFα (0.10 and 0.12 v 1.00 respectively) or 10 ng/ml IL-1α (0.17 and 0.14 v 1.00 respectively). …”
  11. 1031
  12. 1032
  13. 1033
  14. 1034
  15. 1035
  16. 1036
  17. 1037

    AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial by Soraya Allas (4752756)

    Published 2018
    “…AZP-531, a first-in-class UAG analog, was shown to inhibit the orexigenic effect of AG in animals, to improve glycemic control and decrease body weight in humans. We aimed to investigate the safety and efficacy of AZP-531 in patients with PWS for whom no approved treatment for hyperphagia is currently available.…”
  18. 1038
  19. 1039
  20. 1040